Abeona Therapeutics Inc. (ABEO) — Dilution Risk Analysis

Current Snapshot

Abeona Therapeutics Inc. (ABEO) has a DilutionWatch score of 38/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
57,184,017 Source
Public Float
42,603,080 Source
Float as % of Outstanding
74.5%

Dilution Risk Score

Score: 38/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 4 8, SC 13G/A 1, 424B3 1.

FormFiledAccession
4 2026-09-29 0001493152-26-044971
4 2026-09-29 0001493152-26-044972
4 2026-09-29 0001493152-26-044973
4 2026-09-29 0001493152-26-044974
4 2026-09-01 0001493152-26-041068
SC 13G/A 2026-08-14 0000919574-26-005538
4 2026-07-22 0001493152-26-034246
424B3 2026-07-10 0001493152-26-032852
4 2026-07-09 0001493152-26-032740
4 2026-07-09 0001493152-26-032742

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 27 months Source
Three-year share count growth 130.83% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 38/10) Source
Cash Runway
27 months Source
Share Count Growth (3-Year)
130.83% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.